EMVC.LSE EMV Capital plc
- Market cap
- GBX 11.6M
- P/E
- 0.6x
- P/B
- 0.35x
- ROE
- 217.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is EMVC.LSE undervalued?
Graham numberThe Graham number of EMV Capital plc cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
EMV Capital plc fundamental analysis
No fundamental analysis for EMV Capital plc yet.
EMV Capital plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About EMV Capital plc
EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments. The firm focuses to invest in sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, AI and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic dise…
Full company profileEMV Capital plc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
EMV Capital plc annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 518K | 171K | 245K | 735K | 394K | 1.11M | 1.00M | 1.45M | 2.45M | 2.87M | 5.10M |
| Gross Profit | 263K | 91.0K | 167K | 618K | 348K | 989K | 782K | 1.23M | 2.09M | 2.25M | 3.62M |
| Operating Income | -12.4M | -4.43M | -4.11M | -3.63M | -2.46M | -2.96M | -3.74M | -2.64M | -3.39M | -1.88M | -5.98M |
| EBITDA | -12.3M | -4.17M | -3.80M | -3.54M | -2.20M | -2.65M | -3.31M | -2.27M | -3.12M | -1.52M | -5.22M |
| Net Income | -11.2M | -8.32M | -8.33M | -4.49M | -1.61M | -2.39M | -3.09M | -2.64M | -3.06M | -21.0K | 72.6M |
| EPS | -2.19 | -1.36 | -1.10 | -0.57 | -0.29 | -0.13 | -0.14 | -0.11 | -0.13 | 0.00 | 2.59 |
| Balance Sheet | |||||||||||
| Total Assets | 15.1M | 11.8M | 7.20M | 6.17M | 8.07M | 20.7M | 29.0M | 22.5M | 19.5M | 19.8M | 41.7M |
| Total Liabilities | 2.25M | 975K | 1.03M | 1.06M | 1.17M | 2.18M | 3.71M | 5.35M | 5.43M | 6.13M | 8.23M |
| Shareholders' Equity | 16.7M | 15.4M | 12.1M | 5.47M | 6.74M | 18.5M | 25.8M | 17.8M | 15.1M | 15.2M | 33.3M |
| Cash & Short-term Investments | 9.46M | 6.87M | 2.85M | 1.22M | 1.03M | 2.35M | 580K | 347K | 949K | 511K | 656K |
| Total Debt | 208K | 198K | 200K | 437K | 509K | 654K | 1.25M | 2.53M | 1.54M | 2.60M | 810K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -12.8M | -10.6M | -8.28M | -4.12M | -2.79M | -3.48M | -2.56M | -3.14M | -1.78M | -1.24M | -2.43M |
| Capital Expenditure | 470K | 399K | 112K | 6.00K | 89.0K | 62.0K | 601K | 366K | 185K | 32.0K | 8.00K |
| Free Cash Flow | -13.3M | -11.0M | -8.39M | -4.13M | -2.88M | -3.54M | -3.16M | -3.51M | -1.97M | -1.27M | -2.44M |
| Ratios | |||||||||||
| ROE | -67.0% | -54.1% | -68.8% | -82.2% | -23.9% | -12.9% | -12.0% | -14.8% | -20.3% | -0.1% | 217.8% |
| ROA | -74.2% | -70.7% | -115.7% | -72.8% | -20.0% | -11.5% | -10.7% | -11.8% | -15.7% | -0.1% | 174.1% |
| Net Profit Margin | -2,161.2% | -4,864.3% | -3,399.2% | -611.0% | -408.9% | -215.4% | -308.2% | -182.9% | -124.8% | -0.7% | 1,423.9% |
| Debt to Equity | 0.01x | 0.01x | 0.02x | 0.08x | 0.08x | 0.04x | 0.05x | 0.14x | 0.10x | 0.17x | 0.02x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
EMV Capital plc dividends
EMV Capital plc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Aug 25, 2020.
Who owns EMV Capital plc
- Insiders 47.20%
- Institutions 0.15%
- Public & others 52.65%
- Shares outstanding 28.0M
- Free float 15.9M
EMV Capital plc company profile
- Company name
- EMV Capital plc
- Ticker
- EMVC.LSE
- Exchange
- London Exchange
- Sector
- Financial Services
- Industry
- Capital Markets
- Employees
- 21
- Fiscal year end
- December
- Address
- 2nd Floor, London, United Kingdom, W1S 3AN
- Phone
- 44 (0) 20 3011 2234
- Website
- emvcapital.com
About EMV Capital plc
EMV Capital plc is a venture capital firm specializing in seed, growth capital, early and mid stage investments. The firm focuses to invest in sustainability, life science, technology, transformative biomedical, deep tech, semiconductors, industrials, robotics, AI and healthcare technologies focusing on digital health, diagnostics, and therapeutics sectors. It also prefers to invest in companies that significantly improve the health and well-being of people with chronic diseases. Within digital health it focuses on data analytics, wearable technologies, and devices. The firm seeks to invest in companies based in European developed markets, United Kingdom and in the United States. It typically invests up to £15 million ($20.32 million), but may consider larger amounts. It prefers to hold a controlling interest in all principal subsidiaries. The firm prefers to invest through its balance sheet investments. EMV Capital plc was founded on 12 April 2012 and is based in London, United Kingdom with additional office in London, United Kingdom.
EMV Capital plc management
10- Dr. Ilian Petkov Iliev Ph.D.CEO & Director · born 1975
- Mr. Edward Benjamin Peter HooperExecutive Director, General Counsel & Group Company Secretary · born 1979
- Mr. Aneshkumar Ishwarbhai Patel C.A.Group Chief Financial Officer & Secretary · born 1981
- Mr. Tom RuddBusiness Development Manager (EIS Fund)
- Mr. Stephen Daniel CrowePortfolio Chief Financial Officer & Secretary
- Mr. Harry MillerHead of Research
- Mr. Nick SalisburyHead of Capital Raising & Co-Investment
- Ms. Hannah JarvisFinancial Controller
- Mr. Tom HallInvestment Director
- Mr. John Eric ClarksonVenture Partner of Industrials · born 1950